Gynaecological Trials

SOLACE2 Phase II randomised trial comparing immune priming by low dose oral cyclophosphamide plus olaparib versus priming by olaparib alone, prior to combination therapy with olaparib plus durvalumab, versus single agent olaparib alone, in asymptomatic platinum-sensitive recurrent ovarian, fallopian tube or primary peritoneal cancers with homologous recombination repair defects.

2020 Quality Statement


“Excellence in Care”

The provision of excellent care to Riverina Cancer Care Centre (RCCC) patients is achieved by Centre staff and Volunteers’ participation in and observance of the Centre’s Quality system in the performance of their roles. Cooperation, collaboration, communication and mutual respect are critical to provision of excellent care.

Read more...

 

 

Location

RCCC Opening Hours

MON 7:30am - 5:00pm
TUE 7:30am - 5:00pm
WED 7:30am - 5:00pm
THU 7:30am - 5:00pm
FRI 7:30am - 5:00pm
SAT closed
SUN closed

After Hours Emergency: Please access your local hospital emergency department.

Contact Us